Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome ExpressionVincenzo Quagliariello, Nicola Maurea, R. Taibi et al.|Frontiers in Oncology|2021Cited by 45
Improved Survival and Quality of Life Through an Integrative, Multidisciplinary Oncological Approach: Pathophysiological Analysis of Four Clinical Cancer Cases and Review of the LiteratureMassimiliano Berretta, Monica Montopoli, A. Morra et al.|Frontiers in Pharmacology|2022Cited by 6
Polydatin reduces cardiotoxicity of tyrosine kinase inhibitor sunitinib by decreasing pro-oxidative stress, pro-inflammatory cytokines and NLRP3 inflammasome expression.Massimiliano Berretta, Nicola Maurea, Gerardo Botti et al.|Journal of Clinical Oncology|2021Cited by 1